Researching if changes to a gene called APOL1, which are more common in people from African descent, could affect kidney ...
Professor Nick Selby is researching using a new system to better monitor blood pressure in people having haemodialysis ...
Dr Daniyal Jafree, from University College London and the Wellcome Sanger Institute, has received a £250,000 Professor ...
Ellyn Laws shares her struggles with mental health, aiming to help others feel less isolated and show the importance of renal ...
A mother from Surrey has chosen to leave a gift in her Will to fund research into kidney disease, driven by her family’s experience spanning four generations. Lisa, 57, lives with autosomal dominant ...
Goodpasture syndrome is also known as anti-glomerular basement membrane (anti-GBM) disease. This is because antibodies (proteins made by the immune system to protect the body from potentially harmful ...
Dr Christopher Pieri will help us to better predict how PKD develops and identify patients who may need more personalised care by using data.
Kidney Research UK is offering ten funded places on selected BSI bioinformatics training courses. Each place covers one eligible online course and one year of BSI membership. The course must be ...
At stage 1, the kidneys can still perform their normal functions, including filtering waste and extra fluid from your blood. But the presence of damage means that they are under stress, which can ...
It is important that you contact your dialysis unit or the NHS 111 non-emergency medical helpline if you cannot get through to your unit and think you have peritonitis. In severe cases, repeated bouts ...
In most cases, treatment for IgA vasculitis is not needed as symptoms get better without intervention, usually within a month but this can be longer. Patients are carefully monitored usually at home ...
Transitional cell cancer. This cancer starts in the cells that line the bladder, renal pelvis and ureters, which are structures that transport urine from the kidneys to the bladder. Wilms’ tumour.